Nuvalent Inc (NUVL)
70.95
-1.69
(-2.33%)
USD |
NASDAQ |
May 17, 16:00
70.95
0.00 (0.00%)
After-Hours: 20:00
Nuvalent Total Assets (Quarterly): 708.47M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 708.47M |
| December 31, 2023 | 732.38M |
| September 30, 2023 | 425.08M |
| June 30, 2023 | 441.95M |
| March 31, 2023 | 460.99M |
| December 31, 2022 | 482.46M |
| September 30, 2022 | 249.56M |
| Date | Value |
|---|---|
| June 30, 2022 | 263.02M |
| March 31, 2022 | 277.04M |
| December 31, 2021 | 293.82M |
| September 30, 2021 | 307.97M |
| June 30, 2021 | 143.50M |
| March 31, 2021 | 15.25M |
| December 31, 2020 | 10.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.65M
Minimum
Dec 2020
732.38M
Maximum
Dec 2023
343.72M
Average
300.90M
Median
Total Assets (Quarterly) Benchmarks
| Geron Corp | 482.07M |
| Verastem Inc | 123.54M |
| Karyopharm Therapeutics Inc | 204.46M |
| Syndax Pharmaceuticals Inc | 543.03M |
| AnaptysBio Inc | 405.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.43M |
| Shareholders Equity (Quarterly) | 675.04M |